Wai Chun Bio-Technology (HKSE:00660) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


HKSE:00660 Wai Chun Bio-Technology Ltd HKSE:00660
17 GF Score
Price HK$0.48
GF Value HK$0.13
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Wai Chun Bio-Technology Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Wai Chun Bio-Technology's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

HKSE:00660 vs DOW: Margin of Safety % (DCF FCF Based) Comparison

For the Chemicals subindustry, Wai Chun Bio-Technology's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Chun Bio-Technology Margin of Safety % (DCF FCF Based) vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Wai Chun Bio-Technology's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Wai Chun Bio-Technology's Margin of Safety % (DCF FCF Based) falls into.


HKSE:00660
17GF Score
Wai Chun Bio-Technology Ltd HKSE:00660
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Wai Chun Bio-Technology (HKSE:00660) Overvalued in 2026?

Based on GuruFocus' analysis, Wai Chun Bio-Technology stock appears to be overvalued. The current stock price of HK$0.48 is trading 269.2% above its estimated GF Value™ of HK$0.13. GuruFocus considers Wai Chun Bio-Technology to be Significantly Overvalued.

Key valuation signals for HKSE:00660:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: HK$0.13 vs. price of HK$0.48 (269.2% above fair value)
  • GF Score™: 17/100 with 7 warning signs

No single metric tells the full story. See the HKSE:00660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wai Chun Bio-Technology Business Description

Address 26 Harbour Road, Rooms 4001-02, 40th Floor, China Resources Building, Wanchai, Hong Kong, HKG
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
17GF Score

Get the complete analysis for HKSE:00660

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.48
Price
HK$0.13
GF Value